Pharma-Bio Serv, Inc. (PBSV)
OTCMKTS: PBSV · Delayed Price · USD
0.800
0.00 (0.00%)
Mar 22, 2024, 3:01 PM EDT - Market closed
Pharma-Bio Serv Ratios and Metrics
Market cap in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Year | Current | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Capitalization | 19 | 20 | 20 | 24 | 30 | 20 | 24 | 12 | 22 | 21 | 29 | Upgrade
|
Market Cap Growth | - | -1.33% | -18.95% | -17.75% | 46.26% | -16.29% | 109.86% | -47.18% | 1.91% | -25.90% | -19.99% | Upgrade
|
Enterprise Value | 4 | 9 | 6 | 8 | 15 | 5 | 8 | -0 | 8 | 7 | 14 | Upgrade
|
PE Ratio | 29.52 | 14.90 | 19.65 | -11.68 | 14.47 | 9.72 | 18.94 | -8.16 | -85.22 | 13.20 | 12.00 | Upgrade
|
PS Ratio | 1.29 | 1.15 | 1.02 | 1.21 | 1.38 | 1.04 | 1.36 | 0.74 | 1.12 | 0.92 | 1.05 | Upgrade
|
PB Ratio | 1.37 | 1.21 | 1.19 | 1.29 | 1.31 | 0.98 | 1.20 | 0.56 | 1.00 | 0.98 | 1.41 | Upgrade
|
P/FCF Ratio | 11.17 | 10.36 | 34.51 | 30.74 | 20.19 | -8.96 | 6.74 | -5.77 | -19.90 | 709.42 | 9.27 | Upgrade
|
P/OCF Ratio | 11.17 | 10.32 | 33.39 | 30.33 | 19.45 | -9.19 | 6.52 | -7.46 | 30.81 | 57.58 | 8.69 | Upgrade
|
EV/Sales Ratio | 0.26 | 0.55 | 0.30 | 0.38 | 0.71 | 0.25 | 0.46 | -0.01 | 0.42 | 0.28 | 0.51 | Upgrade
|
EV/EBITDA Ratio | 6.74 | 7.18 | 4.74 | -2.00 | 6.63 | 2.72 | 7.11 | 0.13 | 24.47 | 3.08 | 4.30 | Upgrade
|
EV/EBIT Ratio | 11.04 | 8.43 | 4.94 | -1.96 | 6.89 | 2.87 | 7.59 | 0.09 | 402.67 | 3.69 | 4.87 | Upgrade
|
EV/FCF Ratio | 2.22 | 5.00 | 10.13 | 9.52 | 10.43 | -2.15 | 2.30 | 0.06 | -7.41 | 219.43 | 4.47 | Upgrade
|
Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | 0.03 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
Debt / EBITDA Ratio | 0.54 | 0.26 | 0.40 | -0.16 | 1.21 | 0.04 | 0.05 | -0.07 | 0.16 | 0.03 | 0.03 | Upgrade
|
Debt / FCF Ratio | 0.18 | 0.18 | 0.85 | 0.78 | 1.90 | -0.03 | 0.02 | -0.04 | -0.05 | 2.47 | 0.03 | Upgrade
|
Quick Ratio | 4.97 | 8.78 | 9.23 | 8.33 | 7.41 | 6.95 | 8.97 | 12.31 | 9.57 | 10.54 | 8.20 | Upgrade
|
Current Ratio | 5.10 | 9.01 | 9.46 | 8.61 | 7.54 | 7.08 | 9.13 | 12.66 | 10.02 | 10.95 | 8.50 | Upgrade
|
Asset Turnover | 0.76 | 0.85 | 0.94 | 0.84 | 0.72 | 0.73 | 0.70 | 0.70 | 0.81 | 0.97 | 1.19 | Upgrade
|
Interest Coverage | 0 | 0 | -87.56 | 0 | 0 | 0 | -0.37 | 50.54 | -0.41 | 242.56 | 398.57 | Upgrade
|
Return on Equity (ROE) | 4.33% | 8.12% | 6.08% | -11.05% | 9.03% | 10.13% | 6.32% | -6.82% | -1.18% | 7.40% | 11.77% | Upgrade
|
Return on Assets (ROA) | 3.19% | 6.58% | 4.87% | -8.73% | 6.85% | 7.84% | 5.04% | -6.33% | -1.07% | 6.73% | 10.40% | Upgrade
|
Return on Capital (ROIC) | 1.74% | 5.27% | 5.84% | -19.73% | 7.81% | 7.70% | -4.43% | -6.84% | -0.42% | 7.33% | 11.66% | Upgrade
|
Earnings Yield | 3.15% | 6.71% | 5.09% | -8.56% | 6.91% | 10.29% | 5.28% | -12.25% | -1.17% | 7.57% | 8.34% | Upgrade
|
FCF Yield | 8.95% | 9.65% | 2.90% | 3.25% | 4.95% | -11.16% | 14.84% | -17.32% | -5.03% | 0.14% | 10.79% | Upgrade
|
Dividend Yield | 9.38% | 8.83% | 17.42% | 7.08% | 5.81% | 0.00% | 7.13% | 0.00% | 0.00% | 0.00% | 252.74% | Upgrade
|
Payout Ratio | 276.75% | 131.57% | 342.37% | -82.68% | 84.12% | 0.00% | 135.09% | 0.00% | 0.00% | 0.00% | 3031.80% | Upgrade
|
Buyback Yield / Dilution | -0.12% | 0.15% | 0.56% | -0.53% | 0.32% | -0.08% | 0.01% | 0.37% | 0.92% | 1.24% | -0.14% | Upgrade
|
Total Shareholder Return | 9.25% | 8.98% | 17.98% | 6.55% | 6.13% | -0.08% | 7.15% | 0.37% | 0.92% | 1.24% | 252.59% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.